| | | 66283 | | 05.10.2017 | | Sanofi-Aventis (Suisse) SA | | | | | | | | | | | | | 07.06. | | | | 07.06. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Suliqua 100/50 | solution injectable | Injection solution (Insulin Glargine 3.64 mg/ml, Lixisenatidum 50 µg/ml) | A10AE54 | CI | | 02 | Suliqua 100/33 | solution injectable | Injection solution (Insulin Glargine 3.64 mg/ml, Lixisenatidum 33 µg/ml) | A10AE54 | CI |
|
|
